BAYN Stock Overview
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 3/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Bayer Aktiengesellschaft Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €27.00 |
52 Week High | €60.80 |
52 Week Low | €24.98 |
Beta | 0.97 |
1 Month Change | 0.65% |
3 Month Change | -17.43% |
1 Year Change | -55.06% |
3 Year Change | -49.29% |
5 Year Change | -54.58% |
Change since IPO | 98.21% |
Recent News & Updates
Recent updates
Shareholder Returns
BAYN | DE Pharmaceuticals | DE Market | |
---|---|---|---|
7D | 2.5% | 3.2% | 1.7% |
1Y | -55.1% | -28.2% | 2.3% |
Return vs Industry: BAYN underperformed the German Pharmaceuticals industry which returned -27.7% over the past year.
Return vs Market: BAYN underperformed the German Market which returned 2.2% over the past year.
Price Volatility
BAYN volatility | |
---|---|
BAYN Average Weekly Movement | 4.7% |
Pharmaceuticals Industry Average Movement | 6.6% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.1% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: BAYN has not had significant price volatility in the past 3 months.
Volatility Over Time: BAYN's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1863 | 96,931 | Bill Anderson | www.bayer.com |
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.
Bayer Aktiengesellschaft Fundamentals Summary
BAYN fundamental statistics | |
---|---|
Market cap | €26.50b |
Earnings (TTM) | -€2.94b |
Revenue (TTM) | €47.64b |
0.6x
P/S Ratio-9.0x
P/E RatioIs BAYN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BAYN income statement (TTM) | |
---|---|
Revenue | €47.64b |
Cost of Revenue | €19.75b |
Gross Profit | €27.89b |
Other Expenses | €30.83b |
Earnings | -€2.94b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 14, 2024
Earnings per share (EPS) | -2.99 |
Gross Margin | 58.55% |
Net Profit Margin | -6.17% |
Debt/Equity Ratio | 132.3% |
How did BAYN perform over the long term?
See historical performance and comparisonDividends
0.4%
Current Dividend Yield-4%
Payout RatioDoes BAYN pay a reliable dividends?
See BAYN dividend history and benchmarksBayer dividend dates | |
---|---|
Ex Dividend Date | Apr 29 2024 |
Dividend Pay Date | May 02 2024 |
Days until Ex dividend | 4 days |
Days until Dividend pay date | 7 days |
Does BAYN pay a reliable dividends?
See BAYN dividend history and benchmarks